RELX’s fair value estimate has been revised slightly lower from £37.14 to £36.67, while another analyst has raised a separate price target to US$47.20, underscoring that views on upside are far from ...
RELX has told markets on it started 2026 strongly, with growth across all parts of the business supported by demand for AI-enabled data and analytics products. In a trading update released ahead of ...
LexisNexis Risk Solutions, a division of RELX, has integrated its digital health data platform with Agenium's platform. The ...
RELX had a strong 2024, with shares rising 12% since June and 95% over five years, overcoming pandemic-era challenges. Despite solid performance and a positive outlook, I maintain a "sell" rating due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results